Tripotassium Dicitratobismuthate
A bismuth chelate effective in healing gastric and duodenal ulcers. A two week regimen containing tripotassium dicitratobismuthate plus a proton pump inhibitor plus two antibacterials may be effective in patients who have not responded to first-line regimens, it also prevents relapse of duodenal ulcer.
Primary Characteristics
Non-proprietary name: Tripotassium Dicitratobismuthate.
Pharmacokinetics
None recorded.
Advertisement
Indications
Tripotassium Dicitratobismuthate is primarily indicated in conditions like Benign gastric ulcer, Duodenal ulcer.
Tripotassium Dicitratobismuthate is also indicated for secondary conditions like Helicobacter pylori infection.
Contraindications
Tripotassium Dicitratobismuthate is contraindicated in conditions like Renal impairment, Pregnancy.
Dosage
None recorded.
Drug Interactions
None recorded.
Side Effects
Tripotassium Dicitratobismuthate is known to cause more or less tolerable side effects which are usually transient. These include Darkening of stool and tongue, Nausea and vomiting.
Warnings / Precautions
Available Brands
None recorded.
Drug Classification
- 1.17.1.1 — Antacids & antiflatulents